CMS released the 2026 proposed payment rule for hospital outpatient departments and ASCs on July 15. The agency proposed removing 285 mostly musculoskeletal procedure codes from the inpatient-only ...

FDA Commissioner open to revising HRT warning labels due to benefits beyond menopausal symptoms, despite past breast cancer ...

Tibial tubercle avulsion fractures (TTAFs) are uncommon but increasingly observed injuries in young athletes, especially ...

In a new study published in JAMA casting has been found by researchers to be as effective as surgery in the treatment of ...

Ultragenyx's high burn rate, costly R&D, and recent setbacks increase dilution risk, impacting future profitability. Learn ...

New data shows no increased cardiovascular risk of the osteoporosis drug vs anabolic agents — and even suggests a lower risk.

Ultragenyx Pharmaceutical and Mereo BioPharma shares tumble as investors await key phase III UX143 osteogenesis data now set for release at year-end.

Discover how new physician assistant graduates navigate the transition from textbook medicine to clinical reality.

Mereo BioPharma Group plc's ORBIT study for setrusumab in osteogenesis imperfecta moves to final analysis by 2025. Click for ...

A former Premier League striker who claims his top flight career was ended by an unnecessary operation is suing a top surgeon ...